Our findings broaden the understanding of the beneficial effects of DEX pretreatment on TNF-α-induced ototoxicity and also provide basis for designing therapeutic approaches to treat or prevent inflammatory-related hearing loss. The gene discussed is TNF; the disease is hearing loss disorder.